|
| ID |
DDInter1261 |
| Drug Type |
small molecule |
| Molecular Formula |
C34H53No11 |
| Molecular Weight |
651.794
|
| Description |
Naloxegol is a peripherally-selective opioid antagonist used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
|
| ATC Classification |
A06AH03
|
| IUPAC Name |
(1S,5R,13R,14S,17S)-14-(2,5,8,11,14,17,20-Heptaoxadocosan-22-Yloxy)-4-(Prop-2-En-1-Yl)-12-Oxa-4-Azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷. |
| InChI |
Inchi=1S/C34H53No11/C1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2/H3-5,28-29,32,36-37H,1,6-25H2,2H3/T28-,29+,32-,33-,34+/M0/S1 |
| InChI Key |
XNKCCCKFOQNXKV-ZRSCBOBOSA-N |
| Canonical SMILES |
COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|